Literature DB >> 7717746

Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis.

M L Everard1, G Fox, A F Walls, D Quint, R Fifield, C Walters, A Swarbrick, A D Milner.   

Abstract

It has been proposed that a specific IgE response contributes to the immunopathology of acute respiratory syncytial virus (RSV) bronchiolitis but previous work has been difficult to replicate. Indirect evidence that might support this contention was sought by measuring total IgE concentrations in bronchoalveolar lavage (BAL) samples obtained from intubated infants and by attempting to detect mRNA for IgE in cells obtained from both the upper and lower respiratory tract. Evidence of significant mast cell activation was sought by measuring tryptase concentrations in BAL fluid and serum. Detectable concentrations of IgE were found in two of seven BAL samples obtained more than five days after intubation and mRNA for IgE was demonstrated in three of six BAL samples and three of six samples obtained from the upper respiratory tract. Tryptase was detectable in 11 of 12 BAL samples with the two highest values detected on day 1. These values were raised compared with control samples but were not such to suggest that mast cell degranulation is the major contributor to the inflammatory process. These results suggest that IgE may be produced in the airways of infants in response to RSV infection. The relationships between IgE production, RSV infection, and symptoms of acute bronchiolitis remain obscure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717746      PMCID: PMC1510967          DOI: 10.1136/adc.72.1.64

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  32 in total

1.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics.

Authors:  C D Brandt; H W Kim; J O Arrobio; B C Jeffries; S C Wood; R M Chanock; R H Parrott
Journal:  Am J Epidemiol       Date:  1973-11       Impact factor: 4.897

2.  Immunoglobulins in tracheo-bronchial secretion with special reference to IgE.

Authors:  H Deuschl; S G Johansson
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

3.  Interferon in nasal secretions from infants with viral respiratory tract infections.

Authors:  K McIntosh
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

4.  Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma.

Authors:  A C Ferguson; M Whitelaw; H Brown
Journal:  J Allergy Clin Immunol       Date:  1992-10       Impact factor: 10.793

5.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.

Authors:  R C Welliver; D T Wong; M Sun; E Middleton; R S Vaughan; P L Ogra
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

6.  Epidemiology of respiratory viral infection among paediatric inpatients over a six-year period in north-east England.

Authors:  A J Martin; P S Gardner; J McQuillin
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

7.  The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection.

Authors:  R C Welliver; T N Kaul; P L Ogra
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

8.  Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing.

Authors:  D G Sims; P S Gardner; D Weightman; M W Turner; J F Soothill
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-27

9.  Speculation on pathogenesis in death from respiratory syncytial virus infection.

Authors:  P S Gardner; J McQuillin; S D Court
Journal:  Br Med J       Date:  1970-02-07

10.  Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.

Authors:  R B Belshe; L P Van Voris; M A Mufson
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

View more
  8 in total

Review 1.  Early identification of atopy in the prediction of persistent asthma in children.

Authors:  Peter D Sly; Attilio L Boner; Bengt Björksten; Andy Bush; Adnan Custovic; Philippe A Eigenmann; James E Gern; Jorrit Gerritsen; Eckard Hamelmann; Peter J Helms; Robert F Lemanske; Fernando Martinez; Soren Pedersen; Harald Renz; Hugh Sampson; Erika von Mutius; Ulrich Wahn; Patrick G Holt
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

2.  Respiratory status and allergy nine to 10 years after acute bronchiolitis.

Authors:  V Noble; M Murray; M S Webb; J Alexander; A S Swarbrick; A D Milner
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

Review 3.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 4.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  Cytokine responses in primary and secondary respiratory syncytial virus infections.

Authors:  Kelechi Ugonna; Konstantinos Douros; Colin D Bingle; Mark L Everard
Journal:  Pediatr Res       Date:  2016-02-16       Impact factor: 3.756

Review 6.  Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.

Authors:  Jop Jans; Marloes Vissers; Jacco G M Heldens; Marien I de Jonge; Ofer Levy; Gerben Ferwerda
Journal:  Rev Med Virol       Date:  2013-11-14       Impact factor: 6.989

Review 7.  Mast Cells and Natural Killer Cells-A Potentially Critical Interaction.

Authors:  Liliana Portales-Cervantes; Bassel Dawod; Jean S Marshall
Journal:  Viruses       Date:  2019-06-04       Impact factor: 5.048

8. 

Authors:  F Freymuth
Journal:  EMC Pediatr       Date:  2011-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.